Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative StudyLuca Vago, Dietrich W. Beelen, Cristina Toffalori et al.|Blood|2018Cited by 33
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid LeukemiaChristoph Röllig, Martin Bornhäuser, Michael Krämer et al.|Blood|2019Cited by 18
Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid LeukemiaJan Moritz Middeke, Friedrich Stoelzel, Christoph Röllig et al.|Blood|2018Cited by 3
P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY MULTIPARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIONMaximilian Roehnert, Uta Oelschlaegel, Martin Bornhaueser et al.|HemaSphere|2023Cited by 0